OGA and cancer: With advances in proteomics and bioinformatics, we envision that the systematic analyses of protein interactions with OGT/OGA (not restricted to O-GlcNAcylated proteins) will identify new, cancer-specific PPIs and help define the oncogenic properties of these O-GlcNAc cycling enzymes in cancer biology.